Author

N. Weedin

Institution: Annexon Biosciences (United States)

Observed institution: Annexon Biosciences (United States)

OpenAlex ID: A5044351446

P1552: a Phase 2, Open-label Study to Assess Safety, Tolerability, and Clinical Effect of Anx005 in Patients With Warm Autoimmune Hemolytic Anemia and Evidence of Complement Activation

2022 · U. Jaeger, C. Broome, et al. · HemaSphere · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: